Calcitonin Gene-Related Peptide Monoclonal Antibodies Versus Botulinum Neurotoxin a in the Preventive Treatment of Chronic Migraine: An Adjusted Indirect Treatment Comparison Meta-Analysis

• Главные авторы: Yao-Yao Chen (Автор), Xiao-Qian Ye (Автор), Tai-Chun Tang (Автор), Tian-Wei She (Автор), Min Chen (Автор), Hui Zheng (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Purpose: Calcitonin gene-related peptide monoclonal antibodies (CGRPmAbs) are new agents approved by the US Food and Drug Administration for preventive treatment of chronic migraine. Comparison between CGRPmAbs and previously approved Botulinum neurotoxin A (BoNT-A) will inform optimal preventive tr...